Lincoln Krochmal
Corporate Officer/Principal bij Dermatology Foundation
Profiel
Lincoln Krochmal is a member of the Dermatology Foundation and the International Society of Dermatology.
He was a Principal at Bristol Myers Squibb Co. and Unilever Plc.
He was also the Executive Vice President-Research & Development at Connetics Corp.
and the President at Excaliard Pharmaceuticals, Inc. He served as the Chief Medical Officer at Neothetics, Inc. from 2013 to 2016.
He received his undergraduate degree from the University of Wisconsin and his doctorate from The Medical College of Wisconsin, Inc. Currently, Dr. Krochmal holds positions at the Dermatology Foundation and the International Society of Dermatology.
Actieve functies van Lincoln Krochmal
| Bedrijven | Functie | Begin |
|---|---|---|
| Dermatology Foundation | Corporate Officer/Principal | - |
| International Society of Dermatology | Corporate Officer/Principal | - |
Eerdere bekende functies van Lincoln Krochmal
| Bedrijven | Functie | Einde |
|---|---|---|
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 21-01-2016 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Hoofd Techniek/Wetenschap/O&O | 14-04-2011 |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | President | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| UNILEVER PLC | Corporate Officer/Principal | - |
Opleiding van Lincoln Krochmal
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| UNILEVER PLC | Consumer Non-Durables |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
| Dermatology Foundation | |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
| International Society of Dermatology |